Upregulation of IGF-I/IGF-IR signaling is prevalent in several types of leukemia, including AML, B-ALL, T-ALL, CML, and CLL. The gene discussed is IGF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.